ABNB·Consumer Cyclical
Airbnb Insider Selling Warning as Co‑Founder Plans $29.5M Move
Is the latest wave of Airbnb insider selling just routine diversification or a warning signal at current valuations?
Consumer Cyclical
ABNB·Consumer Cyclical
TSLA·Consumer Cyclical·EV & Mobility
Tesla Earnings Warning: Q1 Demand Shock, FSD Lawsuits And Robotaxi Hype
Are Tesla’s ambitious AI and robotaxi promises enough to outweigh weak deliveries, rising FSD lawsuits and a $20 billion capex…
AMZN·Consumer Cyclical·Cloud Computing
Amazon Anthropic Deal: $25B AI Boom Bet on AWS Growth
Can the massive Amazon Anthropic Deal really reignite AWS growth and reshape the race between the biggest AI hyperscalers?
TSLA·Consumer Cyclical·EV & Mobility
Tesla FSD dispute -2.0%: Q1 shock warning for TSLA
Is the Tesla FSD dispute about to turn a fragile Q1 earnings setup into a legal and regulatory storm for…
LCID·Consumer Cyclical·EV & Mobility
Lucid Strategy -5.2% Plunge Tests Lofty Valuation
Can the Lucid Strategy of ultra-premium EVs survive mounting losses, recalls and a sharp share-price slide before cash runs thin?
TSLA·Consumer Cyclical·EV & Mobility
Tesla Robotaxi +3% Rally: Is the AI5 Chip a Game-Changer?
Can the Tesla Robotaxi vision and the new AI5 chip really turn a short squeeze into a lasting comeback for…
TSLA·Consumer Cyclical·EV & Mobility
Tesla AI Strategy +3.0% Rally: Boom or Bubble Ahead for TSLA?
Is the Tesla AI Strategy powering a durable new growth cycle for TSLA, or just another momentum-fueled spike waiting to…
NKE·Consumer Cyclical
Nike Earnings Warning: Flat Q3 Revenue And Dividend Strain
Are the latest Nike Earnings a temporary stumble or the start of a longer slowdown that could even threaten its…
BABA·Consumer Cyclical·China ADRs
Alibaba AI Strategy +4.8% Surge as Cloud Pivot Deepens
Can the revamped Alibaba AI Strategy turn today’s stock surge into a lasting rerating driven by cloud, world models and…
TSLA·Consumer Cyclical·EV & Mobility
Tesla FSD Strategy +7.6% Rally on Insurance Shock
Can Tesla’s FSD subscriptions and insurance discounts really justify a trillion‑dollar valuation and this latest 7.6% stock surge?